John Whyte, the chief medical officer at WebMD, and you're watching Coronavirus in Context ... I mentioned that the rapid antigen test, you have to have sufficient viral load.

a test for SARS-Cov-2, the virus that causes COVID-19). But almost as rapidly as the number of COVID-19 cases rises, the news changes, and it appears that simple, rapidly performed antibody tests ...

Antibody testing is usually done ... performed by a health care professional, but the rapid test can miss some cases. Antigen test. This COVID-19 test detects certain proteins in the virus.

Rapid tests are supposed to detect antibodies in the blood of people ... The rapid testing kits cannot test for coronavirus itself and several scientists have raised concerns over their use ...

Hopes that coronavirus ... a-half million antibody tests, but has not yet found one that is reliable enough to use - and stresses that it will not approve the use of any test until it can be ...

Among our independent judges’ picks for 2020’s Top 10 Innovations were core laboratory technologies—such as a single-cell proteome analyzer and a desktop gene synthesizer—alongside pandemic-focused ...

Serological immunoassays, for example, can indicate whether someone has had a viral infection — particularly important during this coronavirus ... test, the quality of the assay’s antibodies ...

Adoption of Rapid Testing Solutions: Rapid antigen tests have gained popularity in Vietnam due to their quick turnaround time and ease of use. These tests play a crucial role in screening efforts, ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

However, a study published last month in Annals of Internal Medicine finds that antibody testing likely undercounts the number of vaccinated people who have had a previous COVID-19 infection, ...

Invivyd announced that a manuscript preprint conveying data from the CANOPY Phase 3 clinical trial of pemivibart for the pre-exposure prophylaxis of COVID-19, including long-term protection shown ...